JPMorgan Initiates Innovex International at Neutral With $33 Price Target

JPMorgan initiated coverage of Innovex International with a Neutral rating and a $33 price target. The stock, traded on NYSE, has a 5-day change of +2.51% and a year-to-date change of +8.88%.

Original reporting
Published Oct 27, 2026, 9:21 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 27, 2026, 9:36 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
MARKET
Neutral
AI market analysis
Mentioned
$INVX
Relevance
5/10
AlphAI data visualization · based on marketscreener.com
Decision brief

The 30-second read

Low
01

Why it matters

The initiation provides the first analyst price target, offering a reference point for traders.

02

Market read

New coverage may attract attention but limited immediate trading impact.

03

What to watch

Potential upside from upcoming product launches not reflected in the target.

Relevance 5/10Novelty 5/10Timing: pre-market today

Background

JPMorgan initiates coverage on Innovex International with a neutral rating and a $33 price target.

Market effects

Analyst coverage may increase visibility in its sector but no immediate sector shift.

Limited to markets where Innovex International trades.

Minimal global impact.

Counterpoint

Investors may view the neutral rating and $33 target as overly cautious given growth potential.

Key entities

  • Innovex International

    Subject of the analyst initiation.

Related articles

$INVXMedAI 8/10

Innovex (INVX) Q3 2026 Earnings Call Transcript

Innovex (INVX) reported Q3 2026 revenue of $265M, up 8% sequentially and 10% YoY, with adjusted EBITDA of $55M (21% margin). The company highlighted growth in North America, offshore, and Middle East, with new contracts in Venezuela and the North Sea. Innovex expects continued growth in 2027-2028, driven by subsea projects and market share gains. Free cash flow was $32M, 58% of adjusted EBITDA.

$INVXHigh

Innovex Announces Third Quarter 2026 Results

Innovex International, Inc. (INVX) filed an SEC Form 8-K — Results of Operations and Financial Condition. Innovex Announces Third Quarter 2026 Results HOUSTON, October 29, 2026 – Innovex International, Inc. (NYSE: INVX) (“Innovex,” the “Company” or “we”) today announced financial and operating results for the third quarter of 2026. Third Quarter Highlights • Revenue of $265 million,

$INVXMedAI 8/10

Innovex (INVX) Q2 2026 Earnings Call Transcript

Innovex (INVX) reported Q2 2026 revenue of $245 million, up 2% sequentially and 9% year over year, with adjusted EBITDA of $48 million (20% margin) and free cash flow of $30 million. Management cited international/offshore growth and Mexico activity, plus a $95 million TCO Group acquisition completed July 1. Q3 guidance calls for $260 million to $270 million revenue and $51 million to $57 million adjusted EBITDA.

Med

Innovex International, Inc. Q2 2026 Earnings Call Summary

Innovex International, Inc. reported Q2 progress driven by higher international activity and subsea momentum, aided by integration of Dril-Quip and cross-selling. It acquired TCO Group, expecting Q3 2026 revenue of $15M and EBITDA of $3M from TCO. Middle East air freight added a $1.5M margin headwind. TCO was funded with $65M cash and $30M stock.

$INVXMed

Innovex Announces Second Quarter 2026 Results

Innovex International, Inc. (INVX) filed an SEC Form 8-K — Results of Operations and Financial Condition. Innovex Announces Second Quarter 2026 Results HOUSTON, August 3, 2026 – Innovex International, Inc. (NYSE: INVX) (“Innovex,” the “Company” or “we”) today announced financial and operating results for the second quarter of 2026. Second Quarter Highlights • Revenue of $245 million,